Tang Capital Management as of Dec. 31, 2025
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 75 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals (AUPH) | 8.9 | $181M | 11M | 15.95 | |
| Galapagos Nv Spon Adr (GLPG) | 6.3 | $128M | 3.9M | 32.70 | |
| Ptc Therapeutics I (PTCT) | 5.6 | $114M | 1.5M | 75.96 | |
| Celcuity (CELC) | 5.2 | $105M | 1.1M | 99.74 | |
| Mirum Pharmaceuticals (MIRM) | 4.8 | $98M | 1.2M | 78.99 | |
| Tarsus Pharmaceuticals (TARS) | 4.8 | $97M | 1.2M | 81.88 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 4.6 | $93M | 2.3M | 41.25 | |
| Immunocore Hldgs Ads (IMCR) | 4.5 | $91M | 2.6M | 34.71 | |
| Compass Therapeutics (CMPX) | 4.5 | $90M | 17M | 5.37 | |
| Kalvista Pharmaceuticals (KALV) | 3.6 | $74M | 4.6M | 16.15 | |
| Avidity Biosciences Ord (RNA) | 3.2 | $65M | 900k | 72.13 | |
| Anaptysbio Inc Common (ANAB) | 3.2 | $65M | 1.3M | 48.48 | |
| Spyre Therapeutics Com New (SYRE) | 3.1 | $62M | 1.9M | 32.76 | |
| Miragen Therapeutics (VRDN) | 2.8 | $56M | 1.8M | 31.12 | |
| Capricor Therapeutics Com New (CAPR) | 2.4 | $49M | 1.7M | 28.86 | |
| Biontech Se Sponsored Ads (BNTX) | 2.2 | $45M | 470k | 95.20 | |
| Biosante Pharmaceuticals (ANIP) | 1.9 | $38M | 481k | 78.94 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $36M | 80k | 453.36 | |
| Nuvation Bio Com Cl A (NUVB) | 1.7 | $35M | 3.9M | 8.96 | |
| Travere Therapeutics (TVTX) | 1.3 | $27M | 700k | 38.21 | |
| Ventyx Biosciences (VTYX) | 1.3 | $25M | 2.8M | 9.03 | |
| NVIDIA Corporation (NVDA) | 1.2 | $24M | 128k | 186.50 | |
| Precigen (PGEN) | 1.2 | $24M | 5.6M | 4.18 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 1.0 | $21M | 30k | 681.92 | |
| Moderna (MRNA) | 1.0 | $20M | 693k | 29.49 | |
| Viking Therapeutics (VKTX) | 0.9 | $18M | 500k | 35.18 | |
| Atea Pharmaceuticals (AVIR) | 0.8 | $17M | 4.8M | 3.57 | |
| Stoke Therapeutics (STOK) | 0.8 | $16M | 500k | 31.74 | |
| Ideaya Biosciences (IDYA) | 0.8 | $16M | 450k | 34.57 | |
| Meta Platforms Cl A (META) | 0.8 | $15M | 23k | 660.09 | |
| GSK Sponsored Adr (GSK) | 0.7 | $15M | 300k | 49.04 | |
| Journey Med Corp (DERM) | 0.7 | $14M | 1.9M | 7.71 | |
| Lenz Therapeutics (LENZ) | 0.7 | $14M | 865k | 16.00 | |
| Vaxcyte (PCVX) | 0.6 | $13M | 275k | 46.14 | |
| Dianthus Therapeutics (DNTH) | 0.5 | $11M | 265k | 41.21 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.5 | $11M | 290k | 37.42 | |
| Bristol Myers Squibb (BMY) | 0.5 | $11M | 200k | 53.94 | |
| Insmed Com Par $.01 (INSM) | 0.5 | $10M | 60k | 174.04 | |
| Crescent Biopharma (CBIO) | 0.5 | $10M | 872k | 11.86 | |
| Wave Life Sciences SHS (WVE) | 0.5 | $10M | 600k | 17.00 | |
| Teladoc (TDOC) | 0.5 | $9.8M | 1.4M | 7.00 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.4 | $8.6M | 556k | 15.38 | |
| Evolus (EOLS) | 0.4 | $8.3M | 1.2M | 6.65 | |
| Verastem Com New (VSTM) | 0.4 | $8.3M | 1.1M | 7.72 | |
| Urogen Pharma (URGN) | 0.4 | $8.2M | 350k | 23.42 | |
| Heron Therapeutics (HRTX) | 0.4 | $8.1M | 6.3M | 1.30 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $8.0M | 300k | 26.71 | |
| Altimmune Com New (ALT) | 0.4 | $7.7M | 2.1M | 3.61 | |
| Sarepta Therapeutics (SRPT) | 0.4 | $7.5M | 349k | 21.52 | |
| Pliant Therapeutics (PLRX) | 0.4 | $7.5M | 6.1M | 1.22 | |
| Arvinas Ord (ARVN) | 0.3 | $6.8M | 570k | 11.86 | |
| Theravance Biopharma (TBPH) | 0.3 | $6.6M | 351k | 18.71 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $6.2M | 800k | 7.80 | |
| Pmv Pharmaceuticals (PMVP) | 0.3 | $6.2M | 4.9M | 1.25 | |
| Regeneron Pharmaceuticals (REGN) | 0.3 | $6.2M | 8.0k | 771.87 | |
| Biogen Idec (BIIB) | 0.3 | $6.2M | 35k | 175.99 | |
| Corcept Therapeutics Incorporated (CORT) | 0.3 | $5.5M | 157k | 34.80 | |
| Abeona Therapeutics Com New (ABEO) | 0.3 | $5.3M | 1.0M | 5.27 | |
| Immunitybio (IBRX) | 0.2 | $4.6M | 2.3M | 1.98 | |
| Kezar Life Sciences Com New (KZR) | 0.2 | $4.2M | 664k | 6.29 | |
| Coherus Biosciences (CHRS) | 0.2 | $3.9M | 2.7M | 1.42 | |
| Erasca (ERAS) | 0.2 | $3.3M | 900k | 3.72 | |
| Nkarta (NKTX) | 0.1 | $2.7M | 1.5M | 1.85 | |
| Nuvalent Inc-a (NUVL) | 0.1 | $2.2M | 22k | 100.59 | |
| Alexandria Real Estate Equities (ARE) | 0.1 | $2.0M | 40k | 48.94 | |
| Neumora Therapeutics (NMRA) | 0.1 | $1.7M | 967k | 1.79 | |
| Sutro Biopharma Com Shs (STRO) | 0.1 | $1.6M | 140k | 11.57 | |
| Biohaven (BHVN) | 0.1 | $1.6M | 140k | 11.29 | |
| Revolution Medicines (RVMD) | 0.1 | $1.2M | 16k | 79.65 | |
| Fate Therapeutics (FATE) | 0.1 | $1.1M | 1.2M | 0.98 | |
| Zymeworks Del (ZYME) | 0.0 | $912k | 35k | 26.33 | |
| Rocket Pharmaceuticals (RCKT) | 0.0 | $351k | 100k | 3.51 | |
| Adicet Bio Com New (ACET) | 0.0 | $52k | 6.2k | 8.42 | |
| Tscan Therapeutics (TCRX) | 0.0 | $46k | 46k | 1.00 | |
| Cassava Sciences (SAVA) | 0.0 | $14k | 7.1k | 1.98 |